Search details
1.
CD200+ fibroblasts form a pro-resolving mesenchymal network in arthritis.
Nat Immunol
; 25(4): 682-692, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38396288
2.
Rheumatoid arthritis macrophages are primed for inflammation and display bioenergetic and functional alterations.
Rheumatology (Oxford)
; 62(7): 2611-2620, 2023 07 05.
Article
in English
| MEDLINE | ID: mdl-36398893
3.
Metabolites as drivers and targets in rheumatoid arthritis.
Clin Exp Immunol
; 208(2): 167-180, 2022 06 11.
Article
in English
| MEDLINE | ID: mdl-35020864
4.
The mammalian target of rapamycin contributes to synovial fibroblast pathogenicity in rheumatoid arthritis.
Front Med (Lausanne)
; 10: 1029021, 2023.
Article
in English
| MEDLINE | ID: mdl-36817783
5.
Canagliflozin impairs T cell effector function via metabolic suppression in autoimmunity.
Cell Metab
; 35(7): 1132-1146.e9, 2023 07 11.
Article
in English
| MEDLINE | ID: mdl-37230079
6.
Cellular metabolic adaptations in rheumatoid arthritis and their therapeutic implications.
Nat Rev Rheumatol
; 18(7): 398-414, 2022 07.
Article
in English
| MEDLINE | ID: mdl-35440762
7.
Rheumatoid arthritis CD14+ monocytes display metabolic and inflammatory dysfunction, a phenotype that precedes clinical manifestation of disease.
Clin Transl Immunology
; 10(1): e1237, 2021.
Article
in English
| MEDLINE | ID: mdl-33510894
8.
STAT3 Mediates the Differential Effects of Oncostatin M and TNFα on RA Synovial Fibroblast and Endothelial Cell Function.
Front Immunol
; 10: 2056, 2019.
Article
in English
| MEDLINE | ID: mdl-31555281
Results
1 -
8
de 8
1
Next >
>>